Livzon Pharma Publishes 2026 Q3 Report, Profit Distribution Proposal and 2026–2028 Shareholder Return Plan

Bulletin Express
10/23

Livzon Pharmaceutical Group Inc. (Livzon Pharma) released several key corporate documents on 23 October 2026. The English and Chinese versions of the following materials are now available on both the company’s website (www.livzon.com.cn) and the HKEX platform (www.hkexnews.hk):

• 2026 Third Quarterly Report • Circular dated 23 October 2026 • Notice and Proxy Form for the 2026 Second Extraordinary General Meeting • Profit Distribution Proposal for the first three quarters of 2026 • Shareholder Return Plan covering 2026–2028

Registered shareholders who have elected to receive printed communications will receive hard-copy versions with the current mailing. Shareholders preferring printed materials—or those unable to access electronic versions—can request hard copies free of charge by completing the enclosed request form and returning it to the Hong Kong branch share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or by emailing 1513-ecom@vistra.com.

To ensure prompt electronic delivery of future corporate communications and actionable documents, shareholders are advised to provide or update a functional email address via the same request form. Until a valid email address is on record, all notices of publication and actionable documents will be sent in printed form.

Enquiries can be directed to Tricor Investor Services Limited’s hotline at (852) 2980 1333, Monday to Friday, 9:00 a.m.–6:00 p.m. (excluding public holidays). Livzon Pharma’s board secretary, Liu Ning, signed the notice on behalf of the board.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10